February 16, 2015
GLOSTRUP, Denmark, and OSAKA, Japan -- Dako, an Agilent Technologies company ("Agilent") and a worldwide provider of cancer diagnostics, and ONO PHARMACEUTICAL CO., LTD. ("ONO"), today announced a new partnership to develop a potential diagnostic test specifically for use with Opdivo in the treatment of non-small cell lung cancer (NSCLC). This test is being investigated [...]
Lee Biosolutions Announces New Board of Director Members
February 16, 2015
Lee Biosolutions, Inc, a manufacturer and global provider of highly purified enzymes and related proteins for the life science, clinical diagnostic and the biotech healthcare industry, is proud to announce the addition of 3 new members to the Board of Directors reflecting its continued growth and expansion of the business. President and CEO , J. [...]
Bioo Scientific Releases Complete Library Prep Combo Kit to Improve SureSelectXT2 Target Capture
February 14, 2015
Austin, TX -- Today Bioo Scientific announced the launch of the NEXTflex™ Pre- and Post- Capture Combo Kit (Agilent SureSelectXT2 Compatible), a complete Illumina-compatible library prep solution containing all reagents required upstream and downstream of probe hybridization to prepare sequence-ready, multiplexed capture libraries compatible with all SureSelectxt2 bait sets. The NEXTflex Pre- and Post- Capture [...]
Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test
February 13, 2015
SUNNYVALE, Calif.-- Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) for expanded claims on its Xpert® MTB/RIF test. Xpert MTB/RIF detects Mycobacterium tuberculosis complex (MTB-complex) DNA and in positive specimens, provides simultaneous identification of rifampin-resistance associated mutations of the rpoBgene. The expanded product claim enables clinicians [...]
Quanterix Expands Kevin Hrusovsky’s Role to CEO
February 13, 2015
LEXINGTON, MA –- Quanterix Corporation, a leader in ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Chief Executive Officer (“CEO”). Mr. Hrusovsky will continue to serve as Executive Chairman of its Board of Directors. “I am thrilled to have Kevin join the Quanterix team as [...]
Unchained Labs Has a Busy First Day! Raises $25 Million and Closes First Acquisition
February 12, 2015
Pleasanton, CA -– Start-up life sciences tools company Unchained Labs burst onto the scientific scene today, announcing a $25 million Series A Financing and the acquisition of Optim, the world's first and only multiplex protein stability platform for biologics. The financing was led by Novo Ventures, Canaan Partners and TPG Biotech. Unchained Labs is committed [...]
RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics, Inc.
February 12, 2015
BILLERICA, Mass.-RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. (“10X”) of Pleasanton, California. The suit was filed in Federal District Court in Delaware. The patents asserted are U.S. patent numbers 7129091, 822148, 8273573, 8304193, 8329407, [...]
February 12, 2015
MADISON, WISCONSIN -- Promega Corporation announces the release of the 6 × 5 LC-MS/MS Peptide Reference Mix, a novel reagent and software combination. The reagent monitors LC and MS parameters, while the complementary software reports on instrument performance, as well as performance history. The unique peptide formulation saves time by assessing multiple LC and MS [...]
Servomex’s New MiniLaser Platform is Most Sustainable Product Yet
February 11, 2015
When Servomex, the world leader in gas analysis technologies, launched its new MiniLaser platform in January 2015, it also launched its most sustainable product platform to date. With greatly reduced carbon and ecological footprints and improved resource efficiency in manufacturing, the MiniLaser platform also boasts higher energy efficiency with all the associated cost benefits to [...]
February 11, 2015
HILDEN, Germany, and BEIJING, China -– Groundbreaking clinical data published today in the The Lancet medical journal showed that reliance on the 100-year-old tuberculin skin test has significantly overestimated latent tuberculosis infections in China, while results in the same patients using the QuantiFERON-TB Gold (QFT®) from QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) provided [...]
